About this file

This is a Sources Sought Notice issued by the National Cancer Institute (NCI), Division of Cancer Treatment and Diagnosis (DCTD) for market research purposes to identify capable contractors for operating and maintaining the NCI's Chemotherapeutic Agents Repository (NCI-CAR). The requirement involves registration, storage, and distribution of chemicals and drugs for pre-clinical discovery evaluation and development. The NCI-CAR currently maintains an inventory of approximately 500,000 to 600,000 individual chemical samples, processes approximately 400 samples monthly for registration and shipment to NCI testing facilities, and distributes an additional 2,500 samples monthly from inventory to research investigators domestically and internationally in both vialed and plated formats. The contractor shall provide all necessary services, qualified personnel, materials, equipment, and facilities to support compound acquisition activities for the DTP anticancer pre-clinical drug evaluation program and handle receipt, registration, storage, analysis, arraying, and distribution of small molecules and purified natural products, with flexibility to accommodate changing program priorities and handle compounds from other NIH programs including NIAID, NExT, and NCATS.

If an RFP is issued, the anticipated contract vehicle will be an Indefinite Delivery/Indefinite Quantity (IDIQ) with task orders issued as Cost Reimbursement or Firm Fixed Price contracts over a five-year period with an anticipated start date of February 15, 2028. The NAICS code is 541990 (All Other Professional, Scientific, and Technical Services) with a size standard of $16.5 million, and all small business set-aside categories will be considered. Interested organizations must submit tailored capability statements not exceeding 20 single-spaced pages (12-point font minimum) addressing organizational awareness and project approach, staff qualifications and composition, facility and equipment adequacy, organizational capabilities and relevant experience, small business status, commercial product availability, proposed contract type feasibility, and recommended contract vehicles. Capability statements must be submitted electronically in MS Word or PDF format to Lindsay.tonon@nih.gov and erin.dwyer@nih.gov with subject line NCI-DCTD-27-0001 no later than 2:00 PM Eastern Time on Monday, November 30, 2026. This notice does not obligate the Government to award a contract or acknowledge receipt of responses.

View the file

Other files

File Type Posted
Att 1-IDIQ SOW draft.doc DOC document

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Sources Sought Notice for All Potentially Capable, Interested Sources Title: Registration, Storage and Distribution of Chemicals and Drugs for Pre-Clinical Discovery Evaluation and Development Notice Number: NCI-DCTD-27-0001

This Sources Sought Notice is issued as a means of conducting market research to identify any/all parties, to include large and small businesses, having an interest in and the resources to support the requirements for Registration, Storage and Distribution of Chemicals and Drugs for Pre-Clinical Discovery Evaluation and Development. This is NOT a solicitation for proposals, proposal abstracts, or quotations.

Interested parties are expected to review this notice and the draft Statement of Work (SOW) to familiarize themselves with the requirement of this project; failure to do so will be at your firm’s own risk.

Background:

The Drug Synthesis and Chemistry Branch (DSCB) of the Developmental Therapeutics Program (DTP) of the Division of Cancer Treatment and Diagnosis (DCTD) of the National Cancer Institute (NCI) is seeking support services to operate and maintain the National Cancer Institute’s Chemotherapeutic Agents Repository (NCI-CAR). This acquisition is responsible for providing an informational interface with NCI and external investigators that are submitting or requesting research compounds; for updating of the chemical database which includes chemical, inventory, receiving and shipping information; systematic file and record keeping of both current and archival information related to repository activities; and reacquisition of samples for continued chemical and biological studies. Towards this goal, the Program acquires and evaluates about 5,000 single agents each year in anticancer assays. In addition, research samples are provided to the general research community both in vialed and plated format. NCI-CAR is responsible for receiving, storage and distribution services along with curating an inventory of approximately 500,000 - 600,000 individual samples and associated chemical, inventory and distribution data. Approximately 400 samples are received monthly, registered and shipped to NCI testing facilities; an additional 2,500 samples are weighed monthly from inventory and shipped to research investigators both in the U.S. (including NCI) and foreign countries.

Purpose:

The purpose of this Sources Sought Notice is to identify all potentially capable, interested sources. We encourage you to respond to this Sources Sought Notice; particularly if you are a small business. All Small Business Set-Aside categories will be considered.

As a result of this Sources Sought notice, the NCI may issue a Request for Proposal (RFP). THERE IS NO SOLICITATION AVAILABLE AT THIS TIME. However, should such a requirement materialize, no basis for claim against the NCI shall arise as a result of a response to this Sources Sought Notice or the NCI’s use of such information as either part of our evaluation process or in developing specification for any subsequent requirement.

Project Requirements & Objectives:

Independently and not as an agent of the Government, the Contractor shall furnish all the necessary services, qualified personnel, material, equipment and facilities, not otherwise provided by the Government, as needed to perform the attached Draft Statement of Work.

The principal goal of this contract is 1) to support compound acquisition activities related to the DTP anticancer pre-clinical drug evaluation program which seeks to identify new small molecule therapeutic agents and 2) distribution of chemicals to intramural and extramural investigators for research purposes. The primary tasks of the contract are the receipt, registration, storage, analysis, arraying and distribution of small molecules and purified natural products. In addition, a lesser number of compounds from other NIH (e.g. NIAID, NExT, NCATS) programs may be handled through this contract.

This contract is also responsible for providing an informational interface with NCI and external investigators that are submitting or requesting research compounds; for updating of the chemical database which includes chemical, inventory, receiving and shipping information; systematic file and record keeping of both current and archival information related to Repository activities; and reacquisition of samples for continued chemical and biological studies.

The program is highly flexible and the Contractor shall have the flexibility to respond to changing Program priorities.

Anticipated Period of Performance:

It is anticipated that the award from this solicitation will be an Indefinite Delivery/Indefinite Quantity (IDIQ) contract. Task Order(s) issued under this IDIQ contract are anticipated to be Cost Reimbursement (CR) and/or Firm Fixed Price (FFP). The duration of the IDIQ contract(s) will be for five (5) year period. The anticipated start date is on or about February 15, 2028.

If an RFP is issued, NCI anticipates that one (1) IDIQ award may result from the issuance of the RFP.

NAICS Code and Size Standard:

In the event an RFP is issued, the NAICS code for this acquisition is 541990 All Other Professional, Scientific, and Technical Services with a size standard of $16.5 million dollars is being considered.

Capability Statement/Information Sought:

Tailored Capability Statement shall demonstrate a clear understanding of all tasks specified in the draft Statement of Work (SOW). Tailored Capability Statements for this requirement shall address the following areas:

A. The organization’s awareness of project needs and approach to performance to the tasks identified in the attached draft SOW. Specifically, address the following:

1) Adequacy of the offeror's awareness and understanding of the tasks of the project and their proposed approach for completion.

2) Adequacy of the offeror's awareness and understanding of the problems that may be encountered in project execution and their proposed solutions.

3) Suitability of the discussion of the acquisition/documentation activities described in the Statement of Work.

4) Adequacy of procedures described for receiving, storing, inventory and shipping activities.

5) Adequacy of procedures described for accommodating a fluid and unpredictable workload, both in terms of overall workload and related to specific tasks.

6) Adequacy and appropriateness of safety and security measures described for the project including IT-related security.

B. Demonstrate the ability to provide knowledgeable staff to meet the objectives of the attached draft SOW. Specifically, addressing that proposed staff have the experience and the technical experience needed to fulfill the requirements for the draft SOW. Document the composition and qualifications of the proposed staff. Specifically, the following areas:

Education, training, relevant experience (including a background in the understanding of chemical structures, chemical reactivity, chemical hazards, safety procedures, regulatory requirements, domestic and international shipping procedures) suitability and availability of:

1) Project Manager

2) Acquisitions/Documentation Manager

3) Support Staff, including provisions for IT-related support staff C. Demonstrate the adequacy and availability of the proposed space, facilities and equipment for this project including adequacy of terms for leased properties and adequacy of a transition plan into a new facility.

D. Demonstrate organizational capabilities and relevant experience which would ensure the satisfactory performance of all tasks described in the draft SOW.

E. Small Business Capability – Identify your business size and socioeconomic status under the anticipated NACIS code and indicate whether your company could perform as a prime contractor or subcontractor.

F. Commercial vs. Non-Commercial Availability – Identify whether commercial products, platforms, or services could meet all or a substantial portion of the requirement. If so, describe what portion could be met commercially and what would require customization, integration, or custom development.

G. Contract Type – Identify whether any portion of this requirement could be accomplished under a fir-fixed-price contract. If a firm-fixed-price contract is not feasible, identify the proposed contract type.

H. Contract Vehicles – Identify any existing contract vehicles (e.g., GSA Schedules, other Government Wide Acquisition Contracts (GWACs)) that industry recommends for fulfilling this requirement.

Information Submission Instructions:

1. Page Limitations: Interested, qualified organizations are requested to submit a tailored capability statement for this requirement not to exceed twenty (20) single-sided pages excluding all attachments, resumes, charts, and other relevant supporting documentation (single spaced, 12-point font minimum) that clearly details the firm’s ability to perform the aspects of the notice described above and in the draft SOW. All pages must be numbered including attachments, resumes, charts, etc. All responses must include the business concern’s name, point of contact, address, and UEI number.

2. Delivery Point:

All capability statements sent in response to this Sources Sought notice must be submitted electronically (via email) to Lindsay Nelson, Contracting Officer, at Lindsay.tonon@nih.gov and Erin Dwyer, Contracting Officer, at erin.dwyer@nih.gov in MS Word or Adobe Portable Document Format (PDF). The email subject line must specify NCI-DCTD-27-0001. Facsimile responses will not be accepted.

3. Common Cut-Off Date:

Electronically submitted tailored capability statements are due no later than 2:00 PM (Eastern Time) on Monday, November 30, 2026. CAPABILITY STATEMENTS RECEIVED AFTER THIS DATE AND TIME WILL NOT BE CONSIDERED. Comment by Dwyer, Erin (NIH/OD) [E]: update DISCLAIMER AND IMPORTANT NOTES: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation notice may be published on SAM.gov. However, responses to this notice will not be considered adequate responses to a solicitation.

Confidentiality: No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).

NCI-DCTD-27-0001

File details come from the government source that posted it. Updated .